特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

注意欠陥多動性障害(ADHD)治療薬の世界市場:ジェネリック医薬品の生産拡大で市場の成長が加速

Global Market Study on Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics: Increasing Production of Generic ADHD Drugs to Boost Market Growth

発行 Persistence Market Research 商品コード 940724
出版日 ページ情報 英文 177 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.71円で換算しております。
注意欠陥多動性障害(ADHD)治療薬の世界市場:ジェネリック医薬品の生産拡大で市場の成長が加速 Global Market Study on Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics: Increasing Production of Generic ADHD Drugs to Boost Market Growth
出版日: 2020年04月21日 ページ情報: 英文 177 Pages
概要

当レポートは、世界の注意欠陥多動性障害(ADHD)治療薬市場を調査したもので、市場の概要、主なトレンド、市場の環境や背景、需要の分析と予測、医薬品のタイプ別、年齢層別、流通チャネル別、地域別の分析と予測、競合情勢の分析などの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の概要

第3章 市場の主なトレンド

  • 市場に影響を与える主なトレンド
  • 製品開発のトレンド

第4章 市場の環境

  • バリューチェーン分析
  • 医薬品メーカー、販売業者、供給業者のリスト
  • 世界市場-製品概要
  • PEST分析
  • 主な規制
  • 疫学

第5章 市場の背景

  • マクロ経済的要因
  • 市場の力学
    • 成長促進要因
    • 成長阻害要因
    • 市場機会

第6章 世界市場の需要分析と予測

  • 過去の市場分析
  • 現在および将来の市場予測
    • 前年比成長トレンド分析

第7章 市場分析と予測:薬剤の種類別

  • イントロダクション /主な調査結果
  • 過去の市場分析
  • 現在および将来の市場分析と予測
    • 刺激薬
    • 非刺激薬
  • 市場の魅力分析

第8章 市場分析と予測:年齢別

  • イントロダクション /主な調査結果
  • 過去の市場分析
  • 現在および将来の市場分析と予測
    • 小児、青年
    • 成人
  • 市場魅力分析

第9章 市場分析と予測:流通チャネル別

  • イントロダクション /主な調査結果
  • 過去の市場分析
  • 現在および将来の市場分析と予測
    • 病院薬局
    • 専門クリニック
    • 小売薬局
    • 電子商取引
  • 市場魅力分析

第10章 市場分析と予測:地域別

  • イントロダクション
  • 過去の市場分析
  • 現在および将来の市場分析と予測
    • 北米
    • ラテンアメリカ
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
  • 市場の魅力分析

第11章 北米市場の分析と予測

  • イントロダクション
  • 過去の市場分析
  • 市場と予測

第12章 ラテンアメリカ市場の分析と予測

  • イントロダクション
  • 過去の市場分析
  • 市場と予測

第13章 欧州市場の分析と予測

  • イントロダクション
  • 過去の市場分析
  • 市場と予測

第14章 アジア太平洋市場の分析と予測

  • イントロダクション
  • 過去の市場分析
  • 市場と予測

第15章 中東・アフリカ市場の分析と予測

  • イントロダクション
  • 過去の市場分析
  • 市場と予測

第16章 競合分析

  • 競合ダッシュボード
  • 競合分析
    • Pfizer Inc.
    • Eli Lilly and Company
    • Novartis AG
    • GlaxoSmithKline PLC
    • Mallinckrodt Pharmaceuticals
    • Hisamitsu Pharmaceutical Co., Inc.
    • Johnson & Johnson
    • UCB S.A.
    • Purdue Pharma L.P.

第17章 前提条件と略語

第18章 調査手法

図表

List of Tables

  • Table 01: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Drug Type
  • Table 02: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Age Group
  • Table 03: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 04: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
  • Table 05: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Drug Type
  • Table 06: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Age Group
  • Table 07: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 08: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
  • Table 09: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Drug Type
  • Table 10: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Age Group
  • Table 11: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 12: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
  • Table 13: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Drug Type
  • Table 14: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Age Group
  • Table 15: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 16: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
  • Table 17: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Drug Type
  • Table 18: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Age Group
  • Table 19: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 20: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
  • Table 21: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Drug Type
  • Table 22: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Age Group
  • Table 23: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 24: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

List of Figures

  • Figure 01: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Analysis (US$ Mn), 2015-2019
  • Figure 02: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Forecast (US$ Mn), 2020-2030
  • Figure 03: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Absolute $ Opportunity, 2020-2030
  • Figure 04: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share Analysis (%), By Drug Type, 2020 & 2030
  • Figure 05: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Y-o-Y Analysis (%), By Drug Type, 2020-2030
  • Figure 06: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Drug type, 2020-2030
  • Figure 07: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share Analysis (%), By Age Group, 2020 & 2030
  • Figure 08: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Y-o-Y Analysis (%), By Age Group, 2020-2030
  • Figure 09: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Age Group, 2020-2030
  • Figure 10: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share Analysis (%), By Distribution Channel, 2020 & 2030
  • Figure 11: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Y-o-Y Analysis (%), By Distribution Channel, 2020-2030
  • Figure 12: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 13: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share Analysis (%), By Region, 2020 & 2030
  • Figure 14: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Y-o-Y Analysis (%), By Region, 2020-2030
  • Figure 15: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Region, 2020-2030
  • Figure 16: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Drug Type, 2020 (E)
  • Figure 17: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Age Group, 2020 (E)
  • Figure 18: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Distribution Channel, 2020 (E)
  • Figure 19: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Country, 2020 (E)
  • Figure 20: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Analysis (US$ Mn), 2015-2019
  • Figure 21: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Forecast (US$ Mn), 2020-2030
  • Figure 22: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Drug Type, 2020-2030
  • Figure 23: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Age Group, 2020-2030
  • Figure 24: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 25: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Country, 2020-2030
  • Figure 26: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Drug Type, 2020 (E)
  • Figure 27: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Age Group, 2020 (E)
  • Figure 28: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Distribution Channel, 2020 (E)
  • Figure 29: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Country, 2020 (E)
  • Figure 30: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Analysis (US$ Mn), 2015-2019
  • Figure 31: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Forecast (US$ Mn), 2020-2030
  • Figure 32: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Drug Type, 2020-2030
  • Figure 33: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Age Group, 2020-2030
  • Figure 34: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 35: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Country, 2020-2030
  • Figure 36: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Drug Type, 2020 (E)
  • Figure 37: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Age Group, 2020 (E)
  • Figure 38: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Distribution Channel, 2020 (E)
  • Figure 39: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Country, 2020 (E)
  • Figure 40: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Analysis (US$ Mn), 2015-2019
  • Figure 41: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Forecast (US$ Mn), 2020-2030
  • Figure 42: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Drug Type, 2020-2030
  • Figure 43: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Age Group, 2020-2030
  • Figure 44: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 45: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Country, 2020-2030
  • Figure 46: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Drug Type, 2020 (E)
  • Figure 47: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Age Group, 2020 (E)
  • Figure 48: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Distribution Channel, 2020 (E)
  • Figure 49: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Country, 2020 (E)
  • Figure 50: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Analysis (US$ Mn), 2015-2019
  • Figure 51: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Forecast (US$ Mn), 2020-2030
  • Figure 52: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Drug Type, 2020-2030
  • Figure 53: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Age Group, 2020-2030
  • Figure 54: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 55: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Country, 2020-2030
  • Figure 56: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Drug Type, 2020 (E)
  • Figure 57: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Age Group, 2020 (E)
  • Figure 58: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Distribution Channel, 2020 (E)
  • Figure 59: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Share, by Country, 2020 (E)
  • Figure 60: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Analysis (US$ Mn), 2015-2019
  • Figure 61: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Value Forecast (US$ Mn), 2020-2030
  • Figure 62: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Drug Type, 2020-2030
  • Figure 63: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Age Group, 2020-2030
  • Figure 64: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 65: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Attractiveness Analysis by Country, 2020-2030
目次

Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market - Scope of the Report

Persistence Market Research (PMR) recently published a study on the global attention-deficit hyperactivity disorder (ADHD) therapeutics market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the ADHD therapeutics market structure. The market study presents exclusive information about how the attention-deficit hyperactivity disorder therapeutics market will grow during the forecast period of 2020-2030.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in PMR's study in a comprehensive manner. Other information includes market share analysis by region and by product type, which helps in the deep understanding of the market by researchers, suppliers, manufactures, and distributors. This information can help readers understand the quantitative growth prospects of the attention-deficit hyperactivity disorder therapeutics market during the forecast period.

The study is relevant for manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, industry experts can leverage the information and data presented in PMR's study.

The study also includes statistics as well as facts related to macroeconomics factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the attention-deficit hyperactivity disorder therapeutics market. Furthermore, small businesses and new entrants in the ADHD therapeutics market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

Key Questions Answered in PMR's ADHD Therapeutics Market Report

Which regions will continue to remain the most profitable regional markets for ADHD therapeutics market players?

Which factors will induce a change in the demand for ADHD therapeutics during the assessment period?

What are the different opportunities available for emerging players in the attention-deficit hyperactivity disorder therapeutics market?

How are supply-side and demand-side drivers impacting the ADHD therapeutics market?

How will changing trends impact the attention-deficit hyperactivity disorder therapeutics market?

How can market players capture the low-hanging opportunities in the ADHD therapeutics market in developed regions?

Which companies are leading the attention-deficit hyperactivity disorder therapeutics market?

What are the winning strategies of stakeholders in the ADHD therapeutics market to upscale their position in this landscape?

ADHD Therapeutics Market: Research Methodology

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the attention-deficit hyperactivity disorder therapeutics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the attention-deficit hyperactivity disorder therapeutics market study include statistics from government healthcare organizations, medicines journals, research journals, press release, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the attention-deficit hyperactivity disorder therapeutics market, and makes PMR's projection on the growth prospects of the ADHD therapeutics market more accurate and reliable.

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Development Trends

4. Market Context

  • 4.1. Value Chain Analysis
  • 4.2. List of Drug Manufacturers & Distributers/Suppliers
  • 4.3. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market - Product Overview
  • 4.4. PEST Analysis
  • 4.5. Key Regulations
  • 4.6. Disease Epidemiology

5. Market Background

  • 5.1. Macro-Economic Factors
  • 5.2. Market Dynamics
    • 5.2.1. Drivers
    • 5.2.2. Restraints
    • 5.2.3. Opportunity

6. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Drug Type

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2014 - 2018
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2019 - 2029
    • 7.3.1. Stimulants
      • 7.3.1.1. Amphetamine
      • 7.3.1.2. Methylphenidate
      • 7.3.1.3. Dextroamphetamine
      • 7.3.1.4. Dexmethylphenidate
      • 7.3.1.5. Lisdexamfetamine dimesylate
    • 7.3.2. Non-stimulants
      • 7.3.2.1. Atomoxetine
      • 7.3.2.2. Bupropion
      • 7.3.2.3. Guanfacine
      • 7.3.2.4. Clonidine
  • 7.4. Market Attractiveness Analysis By Drug Type

8. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Age Group

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2014 - 2018
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Age Group, 2019 - 2029
    • 8.3.1. Paediatric and Adolescent
    • 8.3.2. Adult
  • 8.4. Market Attractiveness Analysis By Age Group

9. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2014 - 2018
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Speciality Clinics
    • 9.3.3. Retail Pharmacies
    • 9.3.4. e-Commerce
  • 9.4. Market Attractiveness Analysis By Age Group

10. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. Asia Pacific
    • 10.3.5. MEA
  • 10.4. Market Attractiveness Analysis By Region

11. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Drug Type
    • 11.3.3. By Age Group
    • 11.3.4. By Distribution Channel
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Drug Type
    • 11.4.3. By Age Group
    • 11.4.4. By Distribution Channel

12. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Rest of Latin America
    • 12.3.2. By Drug Type
    • 12.3.3. By Age Group
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Drug Type
    • 12.4.3. By Age Group
    • 12.4.4. By Distribution Channel

13. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
    • 13.3.1. By Country
      • 13.3.1.1. U.K.
      • 13.3.1.2. France
      • 13.3.1.3. Germany
      • 13.3.1.4. Italy
      • 13.3.1.5. Spain
      • 13.3.1.6. Russia
      • 13.3.1.7. Rest of Europe
    • 13.3.2. By Drug Type
    • 13.3.3. By Age Group
    • 13.3.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Drug Type
    • 13.4.3. By Age Group
    • 13.4.4. By Distribution Channel

14. Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
    • 14.3.1. By Country
      • 14.3.1.1. Japan
      • 14.3.1.2. China
      • 14.3.1.3. India
      • 14.3.1.4. Australia and New Zealand
      • 14.3.1.5. ASEAN
      • 14.3.1.6. Rest of APAC
    • 14.3.2. By Drug Type
    • 14.3.3. By Age Group
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Drug Type
    • 14.4.3. By Age Group
    • 14.4.4. By Distribution Channel

15. MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
    • 15.3.1. By Country
      • 15.3.1.1. GCC Countries
      • 15.3.1.2. South Africa
      • 15.3.1.3. North Africa
      • 15.3.1.4. Rest of MEA
    • 15.3.2. By Drug Type
    • 15.3.3. By Age Group
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Drug Type
    • 15.4.3. By Age Group
    • 15.4.4. By Distribution Channel

16. Competition Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Deep Dive
    • 16.2.1. Pfizer Inc.
      • 16.2.1.1. Overview
      • 16.2.1.2. Product Overview
      • 16.2.1.3. Key Financial
      • 16.2.1.4. Key Developments
      • 16.2.1.5. Analyst Commentary
    • 16.2.2. Eli Lilly and Company
      • 16.2.2.1. Overview
      • 16.2.2.2. Product Overview
      • 16.2.2.3. Key Financial
      • 16.2.2.4. Key Developments
      • 16.2.2.5. Analyst Commentary
    • 16.2.3. Novartis AG
      • 16.2.3.1. Overview
      • 16.2.3.2. Product Overview
      • 16.2.3.3. Key Financial
      • 16.2.3.4. Key Developments
      • 16.2.3.5. Analyst Commentary
    • 16.2.4. GlaxoSmithKline PLC
      • 16.2.4.1. Overview
      • 16.2.4.2. Product Overview
      • 16.2.4.3. Key Financial
      • 16.2.4.4. Key Developments
      • 16.2.4.5. Analyst Commentary
    • 16.2.5. Mallinckrodt Pharmaceuticals
      • 16.2.5.1. Overview
      • 16.2.5.2. Product Overview
      • 16.2.5.3. Key Financial
      • 16.2.5.4. Key Developments
      • 16.2.5.5. Analyst Commentary
    • 16.2.6. Hisamitsu Pharmaceutical Co., Inc.
      • 16.2.6.1. Overview
      • 16.2.6.2. Product Overview
      • 16.2.6.3. Key Financial
      • 16.2.6.4. Key Developments
      • 16.2.6.5. Analyst Commentary
    • 16.2.7. Johnson & Johnson
      • 16.2.7.1. Overview
      • 16.2.7.2. Product Overview
      • 16.2.7.3. Key Financial
      • 16.2.7.4. Key Developments
      • 16.2.7.5. Analyst Commentary
    • 16.2.8. UCB S.A.
      • 16.2.8.1. Overview
      • 16.2.8.2. Product Overview
      • 16.2.8.3. Key Financial
      • 16.2.8.4. Key Developments
      • 16.2.8.5. Analyst Commentary
    • 16.2.9. Purdue Pharma L.P.
      • 16.2.9.1. Overview
      • 16.2.9.2. Product Overview
      • 16.2.9.3. Key Financial
      • 16.2.9.4. Key Developments
      • 16.2.9.5. Analyst Commentary

17. Assumptions and Acronyms Used

18. Research Methodology